908 Devices Inc. Stock Research

Market Summary

USD8.94+0.68

Market Closed

8.23%

MASS Alerts

1 major insider sales recently.

MASS Stock Price

MASS RSI Chart

MASS Valuation

Market Cap

283.0M

Price/Earnings (Trailing)

-10.38

Price/Sales (Trailing)

5.54

Price/Free Cashflow

-10.67

MASS Price/Sales (Trailing)

MASS Profitability

Operating Margin

57.27%

Return on Equity

-13.88%

Return on Assets

-10.94%

Free Cashflow Yield

-9.37%

MASS Fundamentals

MASS Revenue

Revenue (TTM)

51.0M

Revenue Y/Y

25.92%

Revenue Q/Q

42.24%

MASS Earnings

Earnings (TTM)

-27.3M

Earnings Y/Y

-20.71%

Earnings Q/Q

22.72%

Price Action

52 Week Range

6.8726.00

(Low)(High)

Last 7 days

-0.7%

Last 30 days

-13.7%

Last 90 days

Trailing 12 Months

-47.2%

MASS Financial Health

Current Ratio

11.74

MASS Investor Care

Shares Dilution (1Y)

14.23%

Diluted EPS (TTM)

-0.87

Financials for 908 Devices

* denotes actual numbers (not divided by Millions)
Income Statement (Last 12 Months)					(In Millions)
Description	(%) Q/Q	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3
Revenue	6.8%	51.00	48.00	45.00	42.00	32.00
Gross Profit	9.5%	29.00	27.00	24.00	23.00	17.00
Operating Expenses	8.2%	58.00	53.00	50.00	45.00	39.00
S&GA Expenses	8.0%	41.00	38.00	36.00	32.00	28.00
R&D Expenses	8.9%	17.00	15.00	14.00	13.00	12.00
Interest Expenses	1.9%	0.00	0.00	0.00	0.00	1.00
Net Income	-4.1%	-27.27	-26.19	-25.52	-22.20	-28.91
Net Income Margin	2.4%	-0.53*	-0.55*	-0.57*	-0.53*	-
Free Cahsflow	-11.3%	-26.52	-23.82	-21.26	-29.82	-

* denotes actual numbers (not divided by Millions)
Balance Sheet					(In Millions)
Description	(%) Q/Q	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3
Assets	0.9%	249	247	251	261	166
Current Assets	-6.2%	224	239	243	253	157
Cash Equivalents	-9.1%	194	213	223	224	139
Inventory	4.9%	12.00	11.00	10.00	8.00	8.00
Net PPE	14.1%	3.00	2.00	2.00	2.00	2.00
Goodwill	-	9.00	-	-	-	-
Liabilities	15.0%	53.00	46.00	44.00	46.00	44.00
Current Liabilities	23.6%	19.00	15.00	14.00	15.00	13.00
LT Debt, Non Current	0%	15.00	15.00	15.00	15.00	15.00
Shareholder's Equity	-2.3%	197	201	207	215	123
Retained Earnings	-5.2%	-124	-118	-110	-100	-97.17
Additional Paid-In Capital	0.7%	321	319	317	315	220
Shares Outstanding	0.4%	32.00	32.00	31.00	31.00	28.00

Cashflow (Last 12 Months)					(In Thousands)
Description	(%) Q/Q	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3
Cashflow From Operations	-8.7%	-25,034	-23,020	-19,915	-29,082	-17,530
Share Based Compensation	24.8%	6,076	4,867	3,454	2,504	1,938
Cashflow From Investing	-1803.7%	-15,249	-801	-1,345	-737	-683
Cashflow From Financing	-0.3%	95,300	95,612	95,421	94,725	137,376

Risks for MASS

What is the probability of a big loss on MASS?

97.5%

Probability that 908 Devices stock will be more than 20% underwater in next one year

90.7%

Probability that 908 Devices stock will be more than 30% underwater in next one year.

90.7%

Probability that 908 Devices stock will be more than 40% underwater in next one year.

*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does MASS drawdown profile look like?

Y-axis is the maximum loss one would have experienced if 908 Devices was unfortunately bought at previous high price.

Drawdowns

Returns for MASS

Cumulative Returns on MASS

Which funds bought or sold MASS recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
2023-03-10	BAILLIE GIFFORD & CO	unchanged	-	-2,103	1,897	-%
2023-03-06	Rockefeller Capital Management L.P.	new	-	48,000	48,000	-%
2023-02-17	TRUIST FINANCIAL CORP	reduced	-21.15	-143,559	82,441	-%
2023-02-15	Metropolitan Life Insurance Co/NY	unchanged	-	-13,027	10,973	-%
2023-02-15	Bruce & Co., Inc.	new	-	520,339	520,339	0.13%
2023-02-15	MetLife Investment Management, LLC	unchanged	-	-105,636	91,364	-%
2023-02-15	ALLIANCEBERNSTEIN L.P.	added	32.89	-94,124	150,876	-%
2023-02-15	Belvedere Trading LLC	new	-	78,760	78,760	-%
2023-02-14	Graham Capital Management, L.P.	new	-	100,187	100,187	-%
2023-02-14	MILLENNIUM MANAGEMENT LLC	reduced	-60.53	-5,628,000	1,260,000	-%

Latest Funds Activity

Are funds buying MASS calls or puts?

Calls

Puts

Are funds bullish or bearish(Calls - Puts)?

Net Call Options

No. of funds that own MASS

No. of Funds

MASS Alerts

1 major insider sales recently.

908 Devices News

Schedule 13G FIlings of 908 Devices

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2023	alger associates inc	8.8%	2,805,216	SC 13G/A
Feb 14, 2023	eventide asset management, llc	7.0%	2,230,665	SC 13G
Feb 13, 2023	arch venture fund vii, l.p.	18.1%	5,725,045	SC 13G/A
Feb 01, 2023	blackrock inc.	5.6%	1,763,507	SC 13G/A
Jul 08, 2022	blackrock inc.	7.4%	2,318,894	SC 13G
Feb 09, 2022	ark investment management llc	9.66%	2,996,393	SC 13G/A
Feb 08, 2022	arch venture fund vii, l.p.	18.5%	5,725,045	SC 13G/A

MASS Fair Value

Recent SEC filings of 908 Devices

View All Filings

Date Filed	Form Type	Document
Mar 15, 2023	10-K	Annual Report
Mar 15, 2023	S-8	Employee Benefits Plan
Mar 07, 2023	4	Insider Trading
Mar 07, 2023	8-K	Current Report
Feb 23, 2023	4	Insider Trading
Feb 23, 2023	4	Insider Trading
Feb 17, 2023	4	Insider Trading
Feb 14, 2023	5	Insider Trading
Feb 14, 2023	SC 13G	Major Ownership Report
Feb 14, 2023	SC 13G/A	Major Ownership Report

Latest Insider Trading transactions for MASS

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
2023-03-02	Hunt Anthony	acquired	-	-	2,058	-
2023-02-22	ELOI FENEL M	acquired	-	-	507	-
2023-02-22	George Jeffrey P.	acquired	-	-	507	-
2023-02-16	Knopp Kevin J.	sold	-49,001	10.12	-4,842	president and ceo
2023-02-15	Knopp Kevin J.	sold	-155,976	10.29	-15,158	president and ceo
2023-02-02	Knopp Kevin J.	sold	-420,400	10.51	-40,000	president and ceo
2023-02-02	Griffith Joseph H. IV	sold	-32,758	10.03	-3,266	chief financial officer
2023-02-02	Turner Michael S.	sold	-28,537	10.02	-2,848	vp, general counsel
2023-02-02	Brown Christopher D.	sold	-100,300	10.03	-10,000	chief technology officer
2023-02-01	Fitzpatrick Maura	acquired	-	-	4,427	vp, product management & mktg

About 908 Devices

Kevin J. Knopp

www.908devices.com

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.

MASS Income Statement

2022-09-30

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenue	$ 15,797	$ 12,545	$ 35,209	$ 26,365
Cost of revenue	6,459	5,733	15,108	12,266
Gross profit	9,338	6,812	20,101	14,099
Operating expenses:
Research and development	4,666	3,302	12,864	9,322
Selling, general and administrative	11,826	8,786	32,281	23,318
Total operating expenses	16,492	12,088	45,145	32,640
Loss from operations	(7,154)	(5,276)	(25,044)	(18,541)
Other income (expense):
Interest expense	(33)	(31)	(68)	(446)
Other income, net	928	122	1,340	283
Total other income (expense), net	895	91	1,272	(163)
Net loss	$ (6,259)	$ (5,185)	$ (23,772)	$ (18,704)
Net loss per share, basic	$ (0.20)	$ (0.19)	$ (0.76)	$ (0.68)
Net loss per share, diluted	$ (0.20)	$ (0.19)	$ (0.76)	$ (0.68)
Weighted average common shares outstanding, basic	31,606,484	27,707,858	31,441,611	27,446,149
Weighted average common shares outstanding, diluted	31,606,484	27,707,858	31,441,611	27,446,149
Product and service revenue
Revenue	$ 15,437	$ 12,285	$ 34,074	$ 25,557
Cost of revenue	6,366	5,656	14,768	12,062
License and contract revenue
Revenue	360	260	1,135	808
Cost of revenue	$ 93	$ 77	$ 340	$ 204

MASS Balance Sheet

2022-09-30

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 193,698	$ 224,073
Accounts receivable, net of allowance for doubtful accounts of $1,750	15,231	16,375
Inventory	11,731	7,918
Prepaid expenses and other current assets	3,222	4,527
Total current assets	223,882	252,893
Operating lease, right-of-use assets	4,271	5,182
Property and equipment, net	2,761	1,603
Goodwill	9,200
Intangible assets, net	7,969
Other long-term assets	1,198	1,228
Total assets	249,281	260,906
Current liabilities:
Accounts payable	1,663	1,371
Accrued expenses	8,564	6,961
Deferred revenue	7,419	5,160
Operating lease liabilities	1,432	1,344
Total current liabilities	19,078	14,836
Long-term debt	15,000	15,000
Operating lease liabilities, net of current portion	3,429	4,508
Deferred revenue, net of current portion	12,162	11,958
Deferred income taxes	2,570
Other long-term liabilities	542
Total liabilities	52,781	46,302
Commitments and contingencies (Note 10)
Stockholders' equity:
Preferred stock, $0.001 par value; 5,000,000 shares authorized, no shares issued or outstanding at September 30, 2022 and December 31, 2021, respectively
Common stock, $0.001 par value; 100,000,000 shares authorized; 31,652,058 shares and 31,077,004 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively	32	31
Additional paid-in capital	321,491	315,210
Accumulated other comprehensive loss	(613)
Accumulated deficit	(124,410)	(100,637)
Total stockholders' equity	196,500	214,604
Total liabilities and stockholders' equity	$ 249,281	$ 260,906